This issue focusses on the imaging and management of benign and malignant conditions involving the genitourinary tract. It starts with an overview of the current imaging approach to cystic renal masses (including an update on the Bosniak classification), followed by a review paper on the role of imaging in renal cell carcinoma, with a further paper outlining the indications and technical considerations for renal ablation. There is then a description of prostate artery embolisation for benign prostatic hyperplasia, with a review of the relevant anatomy and techniques involved.

The role of multiparametric MRI and PIRADS classification for prostate cancer is then discussed, followed by a comprehensive review of the different types of radiopharmaceuticals currently used in PETCT imaging for prostate cancer. A further paper describes the postoperative anatomy and surgical complications following cystectomy for bladder cancer, with the final review paper highlighting the increasing role of multiparametric ultrasound in the management of nonpalpable focal testicular lesions.

The submission of this genitourinary issue has coincided with the worse global crisis in a generation, with the outbreak of COVID-19 creating an incredible demand on healthcare systems and frontline doctors throughout the world. It is a testament to the authors of this current issue that despite the very stressful (and strange) times that we currently find ourselves in, they still found time to submit their manuscripts - on time and of such high quality.

I would like to thank the contributors for their tireless contribution in the face of such adversity. I would also like to thank Dana Roth for her continued editorial support and Dr Howard Raymond for giving me yet another opportunity to contribute to this journal.
